ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NASDAQ Market News

iDreamSky talk 2014 Q4

16 Mar 2015 @ 09:35
Also details of a US$20 Million Share Repurchase Program iDreamSky Technology Limited (Nasdaq:DSKY), a Chinese mobile game publishing platform, today announced updates to its previous revenue guidance for the fourth quarter of 20141 and a share repurchase program approved by the board of directors of the Company. The Company estimates its revenue guidance for the […]
 

U.S. Markets Take a Dive

14 Mar 2015 @ 05:55
There are still almost three hours of trading time left in New York, but with the Dow down by more than 228 points to 17,760.87, the Nasdaq down 42.02 points to 4,851, and the S&P 500 down 20.26 points to 2,045.9, it does not appear that the day is going to end well. Normally, I […]
 

AmTrust price of $165m in depositary shares

13 Mar 2015 @ 10:11
What are the details? AmTrust Financial Services, Inc. (Nasdaq:AFSI) today announced that it priced on March 12, 2015 an underwritten public offering of 6.6 million of its depositary shares, each representing a 1/40th interest in a share of its 7.50% Non-Cumulative Preferred Stock, Series D, with a liquidation preference of $1,000.00 per share (equivalent to […]
 

Verigene System sees superbug breakthrough?

13 Mar 2015 @ 10:06
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, offers the VerigeneĀ® Gram-Negative Blood Culture Test (BC-GN), approved by the FDA in June 2014 as the first and only FDA-cleared test that rapidly identifies the five carbapenem resistance genes most commonly associated with carbapenem-resistant Enterobacteriaceae (CRE). Three recent outbreaks...
 

Frequency Electronics talk 2015 results

12 Mar 2015 @ 07:10
How did they do? Frequency Electronics, Inc. (Nasdaq:FEIM) reported revenues for the third quarter of fiscal 2015, which ended January 31, 2015, of $18.4 million, compared to $18.2 million recorded in the third quarter of fiscal 2014. Revenues for the first nine months of fiscal 2015 were $57.4 million compared to $52.1 million recorded in […]
 

Cartesian increases European operations

12 Mar 2015 @ 07:07
What are they up to? Cartesian (Nasdaq:CRTN), a specialist provider of consulting services and managed solutions to the global communications, technology and digital media industries, today announced the expansion of its business development team in the European market with the addition of three new hires. Andy Harper, Andy Weston and Jonathan Hayley join Cartesian’s EMEA […]
 

Manic-Depressive Markets

11 Mar 2015 @ 07:01
“Like any high-stakes business, the highs and lows can make you a manic-depressive person, if you weren’t that way to start with.” Sounds like someone commenting on the stock market – and anyone involved with it – doesn’t it? One day everyone is euphoric. The next, they are ready to admit themselves to the nearest […]
 

Annual Trading Forecast on Amazon (2015)

06 Mar 2015 @ 10:18
Amazon shares (NASDAQ:AMZN) is currently racing north, and this is a bias that should continue this year. The bullish strength began in January and became particularly stronger at the end of January 2015. Since February, the price has gone further north and it is now consolidating. The consolidation is a normal reduction in the momentum […]
 

Calithera Biosciences cuts new deal with TransTech Pharma

06 Mar 2015 @ 10:07
For TransTech Pharma’s Hexokinase II Inhibitor Program Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today an exclusive global license agreement with TransTech Pharma, a clinical stage...
 

Oritani Financial unveils fourth Share repurchase plan

05 Mar 2015 @ 08:06
Repurchase of up to 5% of its outstanding shares of common stock Oritani Financial Corp. (Nasdaq:ORIT), the holding company for Oritani Bank , today announced that its Board of Directors has authorized the repurchase of up to 5% of its outstanding shares of common stock, or 2,205,451 shares. In conjunction with the commencement of a […]
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com